Abstract:BACKGROUND: Studies have shown that the ability of the myocardium to tolerate ischemia becomes significantly compromised with age. During ischemia, several endogenous protective signals are activated to protect the heart from injury, among which extracellular-signal regulated kinase (ERK) 1/2 signaling has been established as playing a pivotal role. However, in aging hearts, the activation of ERK1/2 is compromised. Mitogen-activated protein kinase/ERK kinase (MEK) is a major regulator of ERK1/2 signaling. In the present study, we investigated whether transduction of CaMEK, a constitutively activated MEK, using adeno-associated virus serotype 9 (AAV9) could protect the aging heart against ischemia.METHODS: Myocardial ischemia models were established in aging mice and senescent cardiomyocytes, and AAV9-mediated delivery of CaMEK was applied. Echocardiography, fluorescent staining, transmission electron microscopy, flow cytometry, and immunoblotting were used to explore the effects of CaMEK and their underlying mechanism.RESULTS: AAV9-CaMEK activated ERK1/2 signaling and exerted cardioprotective effects against ischemia in aging hearts. Specifically, CaMEK transduction decreased dynamin-related protein-1 (Drp1) expression and phosphorylation at serine 616, resulting in improved mitochondrial morphology and function in aging ischemic hearts. Furthermore, CaMEK transduction exerted similar protective effects in senescent cardiomyocytes under hypoxia. Meanwhile, with the inhibition of ERK1/2 signaling in senescent cardiomyocytes under hypoxia, the opposite effects were observed, including an increase in mitochondrial fragmentation and aggravation of mitochondrial dysfunction and cell apoptosis.CONCLUSIONS: Our results suggested that AAV9-CaMEK alleviated ischemia-induced myocardium injury in the aging heart, at least in part, through inhibition of mitochondrial fragmentation. Therefore, AAV9-CaMEK is a potential intervention for prevention of ischemia-induced injury of the aging myocardium.

The TrkB-T1 receptor mediates BDNF-induced migration of aged cardiac microvascular endothelial cells by recruiting Willin

BDNF-mediated migration of cardiac microvascular endothelial cells is impaired during ageing.

BDNF-mediated enhancement of inflammation and injury in the aging heart.

Cardiomyocyte-specific Deletion of Endothelin Receptor A Rescues Aging-Associated Cardiac Hypertrophy and Contractile Dysfunction: Role of Autophagy

Transfection of cardiac microvascular endothelial cells using TrkB-shiRNA plasmid

Overexpression of ERBB4 rejuvenates aged mesenchymal stem cells and enhances angiogenesis via PI3K/AKT and MAPK/ERK pathways.

BDNF reverses aging-related microglial activation

Overexpression of ERBB4 Rejuvenates Aged Mesenchymal Stem Cells and Enhances Angiogenesis Via PI3K/AKT and MAPK/ERK Pathways

Abstract 14642: Cardiac-specific Transgenic Inhibition of NF-kB Attenuates Apoptosis and Remodeling in the Aging Heart

Impaired CXCR4 expression and cell engraftment of bone marrow-derived cells from aged atherogenic mice.

Endothelin B receptor inhibition rescues aging-dependent neuronal regenerative decline

Defective CXCR4 expression in aged bone marrow cells impairs vascular regeneration.

Impaired Cross-Activation of Β3 Integrin and VEGFR-2 on Endothelial Progenitor Cells with Aging Decreases Angiogenesis in Response to Hypoxia.

Increased Age-Related Cardiac Dysfunction in Bradykinin B2 Receptor-Deficient Mice.

Knockout of Trpa1 accelerates age-related cardiac fibrosis and dysfunction

Ablation of cardiomyocyte-derived BDNF during development causes myocardial degeneration and heart failure in the adult mouse heart

Impaired Macrophage Migration Inhibitory Factor–AMP-Activated Protein Kinase Activation and Ischemic Recovery in the Senescent Heart

Upregulation of Cardiac Beta(3)-Adrenergic Signaling Promotes Cardiac Aging: Evidence from Chronic Beta(3)-Adrenoceptor Deficiency Mice

Cardiomyocyte-specific Deletion of Endothelin Receptor A (ETA) Obliterates Cardiac Aging Through Regulation of Mitophagy and Ferroptosis.

Akt/eNOS and MAPK Signaling Pathways Mediated the Phenotypic Switching of Thoracic Aorta Vascular Smooth Muscle Cells in Aging/Hypertensive Rats

Constitutive activation of ERK1/2 signaling protects against myocardial ischemia via inhibition of mitochondrial fragmentation in the aging heart